Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries GAAP Gross Profit by Quarter
GAAP Gross Profit (Per Non-GAAP Reconciliation Table) ($M)
Teva Pharmaceutical Industries GAAP Gross Profit: $2,440M in Q3 2026, up 5.9% from a year earlier. That is the highest of the 15 quarters on record here.
Where the Q3 2026 figure comes from
“|| Gross profit | $ | 2,440 | 2,304 | $ | 6,565 | 6,282”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries GAAP Gross Profit ($M), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-gaap-gp
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?